Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 175.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 248.00
  • 52 Week Low: 165.00
  • Currency: UK Pounds
  • Shares Issued: 44.86m
  • Volume: 8,960
  • Market Cap: 78.50m
  • Beta: 0.00

Ergomed Overview

Ergomed is in the pharma and biotech sector and is currently trading at 175.00p per share. In the last year Ergomed 's share price has ranged from 165.00p to 248.00p and brokers are currently rating this stock as 'buy'.

1 Day Chart (16-08-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -8.2% 0.6%
ROCE n/a  
Latest F'cast
P/E 41.7 69.9
PEG n/a n/a
Pr/Revenue 1.6 1.5
Pr/Book 2.3  
Latest F'cast
Revenue 21.4% 13.6%
PBT n/a n/a
EPS -38.2% -40.4%
DPS n/a n/a

Ergomed Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 21.16 0.78 2.40p 63.5 n/a n/a n/a 0.0%
31-Dec-15 30.18 2.07 9.50p 17.8 0.1 +296% n/a 0.0%
31-Dec-16 39.23 (0.22) 6.80p 22.4 n/a -28% n/a 0.0%
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Ergomed Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 54.09 0.31 2.50p 69.9 n/a -40% n/a 0.0%
31-Dec-19 62.37 3.50 8.28p 21.1 0.1 +231% n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Ergomed Company Announcements

Holdings in Company 16-Aug-2018 16:36 RNS
Change of auditor 16-Jul-2018 17:31 RNS
Issue of shares 04-Jul-2018 11:11 RNS

Latest Ergomed Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Ergomed Market Data

Currency UK Pounds
Share Price 175.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 248.00
52 Week Low 165.00
Volume 8,960
Shares Issued 44.86m
Market Cap 78.50m
Beta 0.00

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.51% below the market average61.51% below the market average61.51% below the market average61.51% below the market average61.51% below the market average
43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average43.75% below the sector average
Price Trend
20.27% below the market average20.27% below the market average20.27% below the market average20.27% below the market average20.27% below the market average
13.85% above the sector average13.85% above the sector average13.85% above the sector average13.85% above the sector average13.85% above the sector average
Income Not Available
Growth
34.40% above the market average34.40% above the market average34.40% above the market average34.40% above the market average34.40% above the market average
4.76% above the sector average4.76% above the sector average4.76% above the sector average4.76% above the sector average4.76% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 16-Aug-2018

Time Volume / Share Price
15:40 507 @ 172.10p
14:12 2,000 @ 172.00p
14:08 2,000 @ 172.00p
13:13 4,200 @ 175.00p
12:01 12,975 @ 180.00p

Ergomed Key Personnel

Chair Peter George
CEO Stephen Stamp
COO Jan Petracek
CFO Stuart Jackson

Top of Page